Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation (NCT05723926)
🩺 Plain-English Summary (8th-Grade Level)
Patients with atrial fibrillation (AF) who have had a prior stroke are at very high risk of recurrent ischemic stroke. About 40% of these strokes are due to large emboli which result in large cerebral vessel occlusion (LVO). This randomized control trial aims to address this unmet need by testing whether use of bilateral carotid filter implants in addition to OAC will reduce the risk of stroke in AF patients with recent (e.g. within 12 months) ischemic stroke vs. only OAC.
Who can join: Review the eligibility criteria below.
Location: Mercyhealth Javon Bea Hospital - Riverside — Rockford, Illinois
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (21 Sites)
- Mercyhealth Javon Bea Hospital - Riverside — Rockford, Illinois
- Boston University Medical Center — Boston, Massachusetts
- Weill Cornell Medical Center — New York, New York
- Erlanger Medical Center — Chattanooga, Tennessee
- Methodist University Hospital — Memphis, Tennessee
- Baptist Memorial Hospital-Memphis — Memphis, Tennessee
- Universidade Fedeal Do Parana — Curitiba,
- Hcfmrp-Usp — Monte Alegre,
- HCPA — Porto Alegre,
- Hospital São Rafael — Salvador,
- Hospital de Base de Rio Preto — São José do Rio Preto,
- NEURORAD — São Paulo,
- UNIFESP — São Paulo,
- Hospital Estadual Central de Vitória — Vitória,
- Hamilton General Hospital — Hamilton, Canada
- University Hospital — London, Ontario
- West Georgia Medical Center — Kutaisi,
- K. Eristavi National Center of Experimental and Clinical Surgery JSC — Tbilisi,
- LLC Geo Hospitals Tbilsi Multiprofile Medical Center — Tbilisi,
- Pineo Medical Ecosystem — Tbilisi,
- Tbilisi State Medical University First University Clinic — Tbilisi,
📞 Contact the Study Coordinator
Phone: +972587112116
Email: sagit@javelinmed.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Atrial Fibrillation
- CHAMPION-AF Clinical Trial — Birmingham, Alabama
- Reversal of Atrial Substrate to Prevent Atrial — Calgary, Alberta
- Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients — Rochester, New York
- REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry — Chandler, Arizona
- Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF) — Cleveland, Ohio
- Liraglutide Effect in Atrial Fibrillation — Miami, Florida
Explore by condition: All Atrial Fibrillation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.